Tech Company M&A Transactions
Naurex Acquisition
Naurex was purchased by Allergan Plc. The acquisition occurred on 7/28/2015. The companies indicated that total deal value was $560 million.
Transaction Overview
Company Name
Acquired By
Announced On
7/28/2015
Transaction Type
M&A
Amount
$560,000,000
M&A Terms
Under the terms of the agreement, Allergan will acquire Naurex for a $560 million upfront payment net of cash acquired, $460 million of which is payable upon the closing of the acquisition and $100 million of which is payable by January of 2016 (or upon the closing if the closing has not occurred by such time), as well as potential R&D success-based and sales-threshold milestone payments.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1801 Maple Ave. 4300
Evanston, IL 60201
USA
Evanston, IL 60201
USA
Phone
Website
Email Address
Overview
Naurex Inc. is a clinical-stage company developing novel therapies for depression and other CNS disorders based on a new mechanism of action for modulating the N-methyl-D-aspartic acid receptor (NMDAR).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Norbert Riedel
Chief Financial Officer
James Schulz
Chief Medical Officer
Ronald Burch
Chief Scientific Officer
Joseph Moskal
VP - Bus. Development
Ashish Khanna
Browse more venture capital transactions:
Prev: 7/28/2015: UpCounsel venture capital transaction
Next: 7/28/2015: Revolights venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs